CLOVER HEALTH INVESTMENTS, CORP. /DE 10-K

Item 5. Market for Registrant's Common Equity, Related Stockholder Matters and Issuer Purchases of Equity Securities. Common Stock Our Class A common stock is listed on NASDAQ under the ticker symbol "CLOV." Our Class B common stock is not listed on any securities exchange. Holders At February 20, 2026, there were 346 holders of record of our Class A common stock and 309 holders of record of our Class B common stock. Such figures do not include beneficial owners holding our securities through nominee names. Dividend Policy We have not declared or paid any dividends on shares of common stock and do not intend to pay dividends in the foreseeable future. The declaration, amount, and payment of any future dividend will be at the sole discretion of our Board, and the Board may reduce or discontinue entirely the payment of such dividends at any time. The Board may take into account general and economic conditions, our financial condition and operating results, our available cash and current and anticipated cash needs, capital requirements, contractual, legal, tax, and regulatory restrictions and implications on the payment of dividends to our stockholders, and such other factors as the Board may deem relevant. Issuer Purchases of Equity Securities On May 6, 2024, our Board authorized the repurchase of up to $20.0 million in shares of our Class A common stock over a two year period. The timing, manner, price and amount of any repurchases are determined by the discretion of management, depending on market conditions and other factors. Repurchases were made through a combination of open market purchases and accelerated share repurchases. As of December 31, 2025, there was zero dollars available under the program for share repurchases. The Company repurchased zero shares during the three months ended December 31, 2025. Unregistered Sales of Equity Securities and Use of Proceeds None. Performance Graph 56 Item 6. [Reserved.] 57